SCHEMBL1758342

SCHEMBL1758342

COc1ccc2[nH]c(C)c(-c3ccc(Cl)nn3)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.63
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
GFER P55789 2/20 0.57
EIF2AK2 P19525 3/20 0.53
HTR6 P50406 3/20 0.48
HTR7 P34969 2/20 0.48
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TSHR P16473 1/20 0.47
HTR1D P28221 2/20 0.45
MCL1 Q07820 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
AKR1C2 P52895 1/20 0.43
POLB P06746 1/20 0.43
HTR1A P08908 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR1E P28566 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1757734 0.83 LMNA (0.69) LMNAEIF2AK2HTR6HTR7MAPT
SCHEMBL1758180 0.83 LMNA (0.69) LMNAMEN1KMT2AGFEREIF2AK2
SCHEMBL1757597 0.81 LMNA (0.66) LMNAMEN1KMT2AGFEREIF2AK2
SCHEMBL1758455 0.77 LMNA (1.00) LMNAMEN1KMT2AEIF2AK2HTR6
SCHEMBL31105763 0.77 EIF2AK2 (0.68) MEN1KMT2AGFEREIF2AK2HTR6
SCHEMBL1757976 0.73 MEN1 (0.49) LMNAMEN1KMT2AGFEREIF2AK2
SCHEMBL27145307 0.73 MEN1 (1.00) MEN1KMT2AGFEREIF2AK2HTR6
SCHEMBL30693718 0.73 MEN1 (1.00) MEN1KMT2AGFEREIF2AK2HTR6
SCHEMBL18019742 0.72 ALDH1A1 (0.57) MEN1KMT2AGFERHTR6HTR7
SCHEMBL1720491 0.71 MEN1 (0.57) MEN1KMT2AGFEREIF2AK2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105509-A1 INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS WYETH, LLC (US) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105509-A1 INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS HRH2, CRHR2, CRHR1 LMNA 4342/4885MEN1 3026/4885KMT2A 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.